Concepedia

Hao Tang

HT

Statistics

Publications

85

Citations

8.1K

H-Index

30

Active since

2005

Affiliations

Central South University(Current)

Bristol-Myers Squibb (United States)

Second Xiangya Hospital of Central South University

Sun Yat-sen University

Huazhong University of Science and Technology

Hao Tang is an author at Central South University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2005–2024

85

Publications

85

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.2K citations · Full text

, , +9

Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

Bruno Sangro, Ignacio Melero, Samir Wadhawan et al. · Journal of Hepatology · 2020 · 402 citations · Full text

27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth

Qian Wu, Tomonori Ishikawa, Rosa Sirianni et al. · Cell Reports · 2013 · 345 citations · Full text

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Andressa S. Laino, David Woods, Melinda Vassallo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 237 citations · Full text

Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma

Le Qu, Ze-lin Wang, Qi Chen et al. · European Urology · 2018 · 152 citations

, , +9

1–5 of 85